肥厚性およびケロイド瘢痕治療市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00007237
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 197
Buy Now

[調査レポート]肥厚性瘢痕およびケロイド瘢痕治療市場は、2019年に44億9,899万米ドルと評価され、2027年までに99億7,269万米ドルに達すると予測されています。 2020 年から 2027 年にかけて 10.6% の CAGR で成長すると予想されています。



肥厚性瘢痕とは、損傷によって発生する、肥厚して幅が広く、盛り上がっていることが多い瘢痕を指します。肥厚性瘢痕は通常、外傷または傷害に対する異常な反応の影響です。ケロイドは、外観が隆起し、損傷部位に発生する赤みを帯びた小結節です。ケロイドは体のどの部分でも発生する可能性があります。ただし、胸の上部、肩、背中の上部はケロイドが最も形成されやすい部位です。



肥厚性瘢痕およびケロイド瘢痕治療市場の範囲には、瘢痕の種類、製品の種類、エンドユーザー、および地域が含まれます。肥厚性瘢痕およびケロイド瘢痕治療の市場は、地域に基づいて、北米、ヨーロッパ、アジア太平洋、中東およびアフリカ、南米および中央アメリカに分割されています。このレポートは、市場動向、技術進歩、市場ダイナミクス、世界中の主要市場プレーヤーの競争状況分析などのさまざまなパラメーターに重点を置き、肥厚性およびケロイド瘢痕治療市場の洞察と詳細な分析を提供します。すべての地域にわたる新型コロナウイルス感染症の影響分析も含まれています。さまざまな国でのロックダウン状況により、さまざまな非必須医療製品のサプライチェーンが制限されているため、市場は今後数年間の成長率が鈍化すると推定されています。パンデミックは、傷跡治療を間接的に禁止している美容業界に広く影響を与えています。



肥厚性瘢痕およびケロイド瘢痕治療市場にとって有利な地域



市場洞察



レーザー治療



技術の進歩により、肥厚性瘢痕やケロイド瘢痕の治療に、特に 585 nm PDL、Q スイッチ 532 nm 周波数 2 倍 Nd: YAG、CO2 レーザーなどのレーザーの使用が成功しました。レーザー治療は、手術後の傷跡の形成を防ぐのに役立ちます。痛みやかゆみを軽減し、傷跡によって制限されていた動きが可能になります。この治療法は、火傷による肥厚性瘢痕やケロイド瘢痕の治療に広く採用されています。 「肥厚性熱傷のレーザー管理: 包括的なレビュー」によると、 2020年1月に発表された論文によれば、肥厚性瘢痕の70%以上に熱傷関連損傷が発生します。同様に、世界保健機関 (WHO) によると、火傷は主要な公衆衛生上の問題です。毎年、火傷、電気火傷、その他の火傷により約 265,000 人が死亡しています。さらに、熱傷発生率の 90% は低所得国と中所得国で報告されています。



過剰なコラーゲンの沈着は瘢痕を隆起させる肥厚性瘢痕の生成につながるため、レーザー治療は熱傷に対して効果的であることが証明されています。彼ら。さらに、低侵襲法であるため、瘢痕の厚さ、痛み、術後の回復期間が確実に軽減されます。また、外科的切除の必要性を防ぎ、患部の皮膚の状態の中でもとりわけ皮膚の色素沈着、柔軟性、高さ、かゆみ、質感、熱過敏症を改善するのに役立ちます。この治療法は、特にメディカルツーリズムを選択する人にとって、費用対効果が高いことも証明されています。このような利点があるため、肥厚性瘢痕およびケロイド瘢痕を治すレーザー治療に対する高い需要があります。



瘢痕タイプに基づく洞察



瘢痕タイプに基づいて、肥厚性瘢痕およびケロイド瘢痕治療市場は次のようになります。肥厚性とケロイドに分岐します。肥厚性瘢痕がより一般的であるため、2019年には肥厚性セグメントがより大きなシェアを占めました。さらに、これらの傷跡は元の傷の境界を越えて成長することはなく、最終的には小さくなります。さらに、肥厚性瘢痕の治療では通常、軽傷やレーザー治療の過程でジェル、クリーム、シリコーンシートなどの非侵襲的処置が必要です。したがって、このセグメントは、予測期間中に市場でより高いCAGRを記録すると推定されます。



世界の肥厚性瘢痕およびケロイド瘢痕治療市場、瘢痕タイプ別 - 2019年および2027年



製品タイプに基づく洞察



製品タイプに基づいて、肥厚性およびケロイド傷跡治療市場は、レーザー製品、局所製品、注射剤、その他の製品に分類されます。注射剤セグメントは 2019 年に市場で最大のシェアを占め、予測期間中に市場で最高の CAGR を記録すると推定されています。



エンドユーザーベースの洞察



エンドユーザーベースの洞察ユーザーにとって、肥厚性瘢痕およびケロイド瘢痕治療市場は病院、クリニック、在宅ケアに分割されています。病院部門は 2019 年に市場で最大のシェアを占め、予測期間中に市場で最高の CAGR を記録すると推定されています。



戦略的洞察



パートナーシップなどの無機的戦略、そして、変化する顧客の需要に応え、世界中でブランド名を維持するために、企業は合併と買収を一般的に採用しています。肥厚性瘢痕およびケロイド瘢痕治療市場で活動する市場プレーヤーは、成長する需要を満たすだけでなく、世界中で自社のフットプリントと製品ポートフォリオを拡大するために、製品の発売や拡大などの有機的な戦略も採用しています。



瘢痕タイプ別



p>

  • 肥大性

  • ケロイド


製品タイプ別





  • レーザー製品

    • CO2

    • パルスダイ

    • その他のレーザー製品



  • 局所製品

    • クリーム

    • ジェル

    • シリコーンシート

    • その他の局所製品



  • 注射剤

  • その他の製品


エンドユーザー別





  • 病院

  • クリニック

  • 在宅医療


地理別





  • 北米

    • 米国

    • カナダ

    • メキシコ



  • ヨーロッパ

    • フランス

    • ドイツ

    • イタリア

    • 英国

    • スペイン

    • その他のヨーロッパ



  • アジア太平洋 (APAC)

    • 中国

    • インド

    • 韓国

    • 日本

    • オーストラリア

    • アジア太平洋地域のその他の地域



  • 中東およびアフリカ (MEA)

    • 南アフリカ

    • サウジアラビア

    • UAE

    • MEA の残りの部分



  • 中南米 (SCAM)< ul>
  • ブラジル

  • アルゼンチン

  • その他のSCAM




会社概要



< ul>
  • Alliance Pharma plc

  • Mölnlycke HEALTH CARE AB.

  • Smith & Nephew

  • Newmedical Technology Inc.

  • Rejûvaskin

  • Sonoma Pharmaceuticals, Inc.

  • Suneva Medical

  • HRA Pharma

  • Lumenis

  • Perrigo Company社


  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What are Hypertrophic and Keloid Scars ?

    A hypertrophic scar refers to a thickened, wide, often raised scar that occurs due to an injury. A hypertrophic scar usually is an effect of an abnormal response to a trauma or injury. Keloids are reddish nodules that are raised in appearance and develop at the site of an injury. Keloids may occur on any part of the body; however, the upper chest, shoulders, and upper back are most prone to keloid formation.

    What are the driving factors for the hypertrophic and keloid scar treatment market across the globe?

    The growth of the market is attributed to advantages of laser treatment and increasing incidences of injuries. However, unavailability of universal treatment due to high costs, side effects, and scanty awareness hinder the market growth.

    What is the cost of hypertrophic and keloid scar treatment?

    The costs of the treatments of these scars are much higher, and they may cost US$ 1,000–5,000, or more, per treatment. The cost may also differ from product to product and treatment cycles.

    The List of Companies - Hypertrophic and Keloid Scar Treatment Market

    1. Alliance Pharma plc
    2. Mölnlycke HEALTH CARE AB.
    3. Smith & Nephew
    4. Newmedical Technology Inc.
    5. Rejûvaskin
    6. Sonoma Pharmaceuticals, Inc.
    7. Suneva Medical
    8. HRA Pharma
    9. Lumenis
    10. Perrigo Company plc

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports